Search results
Results From The WOW.Com Content Network
Drug metabolism is the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems. More generally, xenobiotic metabolism (from the Greek xenos "stranger" and biotic "related to living beings") is the set of metabolic pathways that modify the chemical structure of xenobiotics, which are compounds foreign to an organism's normal biochemistry, such as any drug ...
However, if a delay is observed between the drug administration and the drug effect, a temporal dissociation needs to be taken into account and more complex models exist: [6] [7] Direct vs Indirect link PK/PD models; Direct vs Indirect response PK/PD models [8] Time variant vs time invariant; Cell lifespan models; Complex response models
Beta phase: A phase of gradual decrease in plasma concentration after the alpha phase. The decrease is primarily attributed to drug elimination, that is, metabolism and excretion. [10] Additional phases (gamma, delta, etc.) are sometimes seen. [11] A drug's characteristics make a clear distinction between tissues with high and low blood flow.
Index inducer or just inducer predictably induce metabolism via a given pathway and are commonly used in prospective clinical drug-drug interaction studies. [2]Strong, moderate, and weak inducers are drugs that decreases the AUC of sensitive index substrates of a given metabolic pathway by ≥80%, ≥50% to <80%, and ≥20% to <50%, respectively.
Pharmacokinetics is the movement of the drug in the body, it is usually described as 'what the body does to the drug' the physico-chemical properties of a drug will affect the rate and extent of absorption, extent of distribution, metabolism and elimination. The drug needs to have the appropriate molecular weight, polarity etc. in order to be ...
He has also worked on drug discovery, drug metabolism, and translational research. Swamidass is the founder of "Peaceful Science," where he writes regarding the advancement of the civic practice of science. [2] He also serves as an Associate Editor for BMC Medical Informatics and Decision Making. In 2019 he published The Genealogical Adam and Eve.
Drug Metabolism and Disposition was established in 1973 by Kenneth C. Leibman. [ 3 ] [ 4 ] The initial frequency was bimonthly (six annual issues); it increased to monthly in 1995. The journal was published on behalf of the society by Williams & Wilkins until the end of 1996.
Sometimes drugs are formulated in an inactive form that is designed to break down inside the body to form the active drug. These are called prodrugs.The reasons for this type of formulation may be because the drug is more stable during manufacture and storage as the prodrug form, or because the prodrug is better absorbed by the body or has superior pharmacokinetics (e.g., lisdexamphetamine).